The Eastman and SAP collaboration will leverage the blockchain-based platform of GreenToken to provide visibility through the value chain of sustainable products, such as the specialty plastics produced with Eastman’s molecular recycling technologies
Construction of the first facility is planned for early 2022, with eMethanol available early 2024
Company is donating $100,000 to the U.S. India Friendship Alliance, helping the organization provide 250 oxygen concentrators to hospitals and medical facilities across India
Kansai reported revenue, EBITDA and PAT growth of 35.1%, 59% and 89.1%, respectively.
Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021
The company has posted net profit of Rs.269.32 crores for FY ended March 31, 2021
BBIL had proposed to carry out Phase II/III clinical trial of Covaxin in the age group of 2 to 18 years
They intend to work together to develop urbanization solutions ?envisioned to decarbonize cities
BASF’s simulation technology optimizes loading behavior and enables metal replacement
Its core operating income was ¥147.6 billion
Net sales from continuing operations of $753 million, an increase of 10% compared with $687 million in the prior year period
Provide innovative, eco-friendly solutions and service packages for dealers to meet volatile organic compounds targets
The company has reported total income of Rs.76.49 crores during the 12 months period ended March 31, 2021
The company reported total income of Rs.2175.83 crores during the period ended March 31, 2020.
The High Court of Mumbai has ruled in favour of Sadhana Nitro Chem in the writ petition that it filed against Cibil Transunion
The agreement will help ensure wider reach and access to patients in India
It has reported total income of Rs.356.23 crores during the 12 months period ended March 31, 2021
It posted net profit of Rs.221.83 crores for the 12 months period ended March 31, 2021
It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021
The additional allocation of Tocilizumab will ensure sufficient availability for COVID-19 patients and augment the government’s efforts to fight the pandemic
Subscribe to our newsletter & stay updated.
